Lucentis

Lucentis (ranibizumab) is a medication used to treat eye conditions caused by abnormal blood vessel growth and leakage, such as neovascular age-related macular degeneration (AMD). It works by blocking a protein called vascular endothelial growth factor (VEGF), which promotes the growth of these problematic blood vessels. By inhibiting VEGF, Lucentis helps reduce fluid buildup, bleeding, and vision loss, ultimately preserving or improving eyesight. It is administered through a series of injections into the eye by an ophthalmologist, and its use has significantly advanced the management of these sight-threatening conditions.